Behavioral Tolerance Did Not End Every Adverse Finding in High-Dose Animal Experiments
A reduction in an early drug response did not mean that every adverse effect disappeared during repeated exposure. A historical chapter described animal experiments in which tolerance to initial depression preceded a different pattern of behavioral and pathological findings.
The observed pattern changed over time
Nahas summarized repeated-administration studies using high daily cannabinoid or cannabis-extract doses in rats and monkeys. Early generalized depression diminished, while later observations included hyperactivity and other adverse findings.
The chapter explicitly acknowledged that the doses were far out of proportion to heavy human cannabis consumption. That qualification limits direct application to ordinary human exposure.
Tolerance is defined by a particular response
Becoming less responsive on one behavioral measure does not demonstrate protection against a different endpoint. Adaptation to initial depression and later tissue or behavioral abnormalities are not logically incompatible.
The experiments therefore should not be reduced to either complete recovery or uniform worsening. Their interpretation depends on which response was measured and when it was measured.
Do not translate extreme regimens into ordinary-use risks
The chapter’s summaries do not establish the frequency of these findings in people or a comparable human regimen. Species, preparation and exposure intensity remain central.
The supported methodological point is narrower: evidence of tolerance needs an endpoint, and it cannot serve as a general certificate of safety. Conversely, adverse findings under an extreme animal regimen cannot by themselves quantify risk from a different human exposure.
Related: Interpreting cannabis tolerance evidence.
Research cited
Gabriel G. Nahas. Marihuana: Toxicity and Tolerance. Historical book chapter, pp. 16–36.
